1. Sadati L, Golchini E. Prinvipies of Sterizilation & Disinfection. 2th ed. 2014.

2. Feigin RD, Cherry JD, Gail JD, LK S. Textbook of pediatric infectious disease. 5th ed. 2004.

3. Masomi H. National Guidline of Nasocomial InfectionSurveillance. Tehran: Center of Deases Management; 2008.

4. Kousha A, Kavakebi N, Alikhah F. Reporting problems of National Nosocomial Infections Surveillance System (NNIS) in Tabriz hospitals. J Health Administration 2016; 19(63).

5. Zahraei M PSP. Surveillance Guidline In Promotion Of Hand Hygiene. 1ed. 2008.

6. Kaufmann SH, MS. Topley and Wilson's microbiology and microbial infections: Arnold. 2005.

7. Villaseca JM, Hernández U, Sainz-Espuñes TR, Rosario C, Eslava C. Enteroaggregative Escherichia coli an emergent pathogen with different virulence properties. Rev Latinoam Microbiol 2005; 47: 140-59.

8. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008; 29(11): 996-1011.

9. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrobial Chemotherapy 2010; 66(1): 1-14.

10. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999; 281(8): 736-8.

11. Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, et al. Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV-and CTX-M-type β-lactamases. Antimicrob Agents Chemotherapy 2003; 47(11): 3554-60.

12. O'Hara CM. Manual and automated ins‌trum‌entation for identification of Entero‌bacteri‌aceae and other aerobic gram-negative bacilli. Clin Microbiol Rev 2005; 18(1): 147-62.

13. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proceedings National Academy Sci 1995; 92(5): 1664-8.

14. Vatopoulos A, Philippon A, Tzouvelekis L, Komninou Z, Legakis N. Prevalence of a trans‌ferable SHV-5 type β-lactamase in clinical iso‌lates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrobial Chemotherapy 1990; 26(5): 635-48.

15. Mirsalehian A, Jabal AF, Mirafshar S, Bazarjani F, Gorjipour A, Goli H. Determination of antimicrobial resistance patterns and extended spectrum β lactamases in clinical isolates of E. coli. 2008.

16. Fazeli H HM, Mohammadi-Ghalaei P. The frequency and drug resistance profile of extended spectrum β-Lactamase producing Escherichia coli in clinical samples of Alzahra Hospital, Isfahan. J Shahrekord Univ Med Sci 2009; 10(4): 58-64. [in Persian]

17. Moosavian M, Deiham B. Distribution of TEM, SHV and CTX-M Genes among ESBL-producing Enterobacteriaceae isolates in Iran. African J Microbiol Res 2012; 6(26): 5433-9.

18. Zaniani FR, Meshkat Z, Nasab MN, Khaje-Karamadini M, Ghazvini K, Rezaee A, et al. The prevalence of TEM and SHV genes among exte‌nded-spectrum beta-lactamases producing Escheri‌chia coli and Klebsiella pneumoniae. Iran J Basic Med Sci 2012; 15(1): 654.

19. Yazdi M, Nazemi A, Mirinargasi M, Khatami Nejad M, Sharifi Sh BKM. Prevalence of CTX beta-lactamase resistance gene among Escherichia coli, isolated from urinary tract in Tehran. Lab Sci J 2011; 4: 48-54.

20. Soltan Dallal MM, Aghamirzaei HM, Mehr‌abadi JF, Lari AR, Sabbaghi A, Eshraghian MR, et al. Molecular detection of TEM and AmpC (Dha, mox) broad spectrum β-lactamase in clinical isolates of Escherichia coli. Tehran Univ Med J 2010; 68(6).

21. Daoud Z, Hakime N. Prevalence and susceptibility patterns of extended-spectrum beta‌lactamase-producing Escherichia coli and Kleb‌siella pneumoniae in a general university hospital in Beirut, Lebanon. Rev Esp Quimioter 2003; 16(2): 233-8.

22. Chaikittisuk N, Munsrichoom A. Extended-spectrum β-Lactamase-producing escherichia coli and Klebsiella pneumoniae in children at Queen Sirikit National Institute of Child Health. J Infect Dis Antimicrob Agents 2007; 24(3): 107-15.

23. Olesen B, Hansen DS, Nilsson F, Frimodt-Møller J, Leihof RF, Struve C, et al. Prevalence and characteristics of the epidemic multi-resistant Escherichia coli ST131 clonal group among extended-spectrum β-lactamase (ESBL)-producing E. coli in Copenhagen. J Clin Microbiol 2013; 00346-13.

24. Al-Agamy MH, Shibl AM, Hafez MM, Al-Ahdal MN, Memish ZA, Khubnani H. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131. Ann Clin Microbiol Antimicrobials 2014; 13(1): 4.

25. Hussain A, Ewers C, Nandanwar N, Guenther S, Jadhav S, Wieler LH, et al. Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of seq‌uence type 131 isolates of the CTX-M-15 extended-spectrum-β-lactamase-producing lineage. Anti‌mi‌crob Agents Chemotherapy 2012; 56(12): 6358-65.

26. Wang S, Zhao SY, Xiao SZ, Gu FF, Liu QZ, Tang J, et al. Antimicrobial resistance and molecular epidemiology of Escherichia coli causing bloodstream infections in three hospitals in Shanghai, China. PloS One 2016; 11(1): e0147740.

27. Hawser SP, Bouchillon SK, Lascols C, Hackel M, Hoban D, Badal R, et al. Susceptibility of European Escherichia coli clinical isolates from intra‐abdominal infections, extended‐spectrum β‐lac‌t‌a‌‌mase occurrence, resistance distribution, and molecular characterization of ertapenem‐resistant isolates (SMART 2008–2009). Clin Microb Infection 2012; 18(3): 253-9.

28. Jalalpoor S, Mobasherizadeh S. Frequency of ESBLs in Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized and out-patients with urinary tract infection in selective centers in Esfahan (2009-2010). Razi J Med Sci 2011; 18(85).

29. Nakhai moghadam M, Mashregi S. Deter‌mination of antibiotic resistance pattern of Escheri‌chia coli isolates and the prevalence of broad-spectrum beta-lactamases among them. J Sabzevar Univ Med Sci 2010; 16(4): 228-33.

30. Stratchounski LS, Kozlov RS, Rechedko GK, Stetsiouk OU; Chavrikova E. Antimicrobial resistance patterns among aerobic Gram-negative bacilli isolated from patients in intensive care units: results of a multicenter study in Russia. Clin Microbiol Infection 1998; 9: 497-507.

31. Daza R, Jose´ Gutie´rrez, Gonzalo Pie´drola Antibiotic susceptibility of bacterial strains isolated from patientswith community-acquired urinary tract infections. Int J Antimicrob Agents 2001; 18: 211–215.

32. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. New England J Med 2001; 345(14): 1007-13.

33. Ling TK, Xiong J, Yu Y, Lee CC, Ye H, Hawkey PM. Multicenter antimicrobial suscep‌tibility survey of gram-negative bacteria isolated from patients with community-acquired infections in the People's Republic of China. Antimicrob Agents Chemother 2006; 50: 374-8.

34. Ndugulile F, Jureen R, Harthug S, Urassa W, Langeland N. Extended Spectrum β-Lactamases among Gram-negative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania. BMC Infectious Dis 2005; 5(1): 86.

35. Aminzadeh Z, Zare dehabadi M, Gachkar L, Sahhoseini MR. Frequency of gram-negative infec‌tions and determination of antibiotic resistance pattern in loghman hakim hospital in 2003. Iran J Infection Dis Tropical Med 2004; 10(30): 27-33.